# fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder

> **NCT00332046** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 57 (—)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** GW679769

## Key facts

- **NCT ID:** NCT00332046
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 57 (—)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332046, "fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00332046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*